Research Publications

A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes.

Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.

Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model.

An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.

Scientific and therapeutic advances in antiplatelet therapy.

Thyrotoxicosis and the cardiovascular system: subtle but serious effects.

Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors.

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.

Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials.